Page last updated: 2024-11-12

4-nitro-7-piperazino-2,1,3-benzoxadiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitro-7-piperazino-2,1,3-benzoxadiazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10586684
CHEMBL ID551285
SCHEMBL ID2864894
MeSH IDM0395005

Synonyms (26)

Synonym
4-nitro-7-piperazino-2,1,3-benzoxadiazole
4-nitro-7-piperazinobenzofurazan
nbd-pz
139332-66-4
A5554
CHEMBL551285
A807523
4-nitro-7-piperazin-1-yl-2,1,3-benzoxadiazole
4-nitro-7-(1-piperazinyl)-2,1,3-benzoxadiazole
AKOS005888302
SCHEMBL2864894
4-nitro-7-(piperazin-1-yl)benzo[c][1,2,5]oxadiazole
4-nitro-7-piperazino benzofurazan
J-100218
DTXSID20442160
4-nitro-7-piperazino-2,1,3-benzoxadiazole, nbd-pz, for hplc labeling
mfcd00191507
4-nitro-7-piperazinobenzofurazan, for hplc derivatization, >=99.0%
4-nitro-7-(piperazin-1-yl)-2,1,3-benzoxadiazole
AS-68764
FT-0701634
TQP0982
nsc796323
nsc-796323
D95936
4-methyl-3-phenyl-2-(pyridin-3-yl)pentanenitrile
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID419411Cellular uptake in F14512 co-cultured human NAMALWA cells assessed as decrease in fluorescence at 0.1 uM after 2 hrs by FACS analysis relative to control2009Bioorganic & medicinal chemistry letters, May-01, Volume: 19, Issue:9
Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system.
AID419410Cellular uptake in human NAMALWA cells assessed as fluorescence intensity at 1 uM after 2 hrs by FACS analysis relative to control2009Bioorganic & medicinal chemistry letters, May-01, Volume: 19, Issue:9
Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (90.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.96 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]